Cerus (CERS) Shares Outstanding (2010 - 2026)
Cerus (CERS) posted Shares Outstanding (Entity) of $201.5 million for Q2 2026, up 0.6% sequentially from $200.3 million in Q1 2026, and up 5.19% YoY from $191.6 million in Q2 2025.
Cerus (CERS) Shares Outstanding (2010 - 2026) Analysis & Trends
Cerus has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $201.5 million in Q2 2026.
- Quarterly Shares Outstanding (Entity) rose 5.19% year-over-year to $201.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $201.5 million (up 5.19% YoY) and the FY2025 annual result came in at $192.1 million, up 3.43% from the prior year.
- Shares Outstanding (Entity) grew to $201.5 million in Q2 2026 per CERS's latest filing, from $200.3 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $201.5 million in Q2 2026 and troughed at $176.8 million in Q1 2022.
- A 5-year average of $185.7 million and a median of $185.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) increased 2.06% in 2023, then advanced 5.19% in 2026.
- Over 5 years, Shares Outstanding (Entity) stood at $177.6 million in 2022, then grew by 2.06% to $181.2 million in 2023, then advanced by 2.49% to $185.8 million in 2024, then advanced by 3.43% to $192.1 million in 2025, then advanced by 4.88% to $201.5 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $201.5 million, $200.3 million, and $192.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | 200.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 200.57 Mn |
| Mar 31, 2026 | 194.14 Mn |
| Dec 31, 2025 | 190.59 Mn |
| Sep 30, 2025 | 191.83 Mn |
| Jun 30, 2025 | 191.30 Mn |
| Mar 31, 2025 | 187.07 Mn |
| Dec 31, 2024 | 184.56 Mn |
| Sep 30, 2024 | 185.42 Mn |
| Jun 30, 2024 | 184.98 Mn |
| Mar 31, 2024 | 182.09 Mn |
| Dec 31, 2023 | 180.27 Mn |
| Sep 30, 2023 | 180.94 Mn |
| Jun 30, 2023 | 180.61 Mn |
| Mar 31, 2023 | 178.27 Mn |
| Dec 31, 2022 | 176.55 Mn |
| Sep 30, 2022 | 177.24 Mn |
| Jun 30, 2022 | 176.94 Mn |
| Mar 31, 2022 | 174.48 Mn |
| Dec 31, 2021 | 171.28 Mn |
| Sep 30, 2021 | 171.90 Mn |